dazmegrel has been researched along with cyclosporine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barros, EJ; Boim, MA; Braquet, P; dos Santos, OF; Pirotzky, E; Schor, N | 1 |
| Gladue, RP; Newborg, MF | 1 |
2 other study(ies) available for dazmegrel and cyclosporine
| Article | Year |
|---|---|
Nephrotoxicity of cyclosporine: the role of platelet-activating factor and thromboxane.
Topics: Animals; Blood Pressure; Cyclosporine; Glomerular Filtration Rate; Imidazoles; Kidney; Male; Platelet Activating Factor; Rats; Rats, Inbred Strains; Reference Values; Renal Circulation; Thromboxane A2; Thromboxane-A Synthase | 1991 |
The protective effects of the thromboxane synthetase inhibitor Dazmegrel on nephrotoxicity in cyclosporine-treated rats.
Topics: Acetylglucosaminidase; Amino Acid Sequence; Animals; Chromatography, Gel; Chromatography, High Pressure Liquid; Creatinine; Cyclosporine; Drug Antagonism; Encephalomyelitis, Autoimmune, Experimental; Imidazoles; Kidney; Kidney Tubules, Proximal; Male; Molecular Sequence Data; Nephrotic Syndrome; Rats; Rats, Inbred F344; Thromboxane B2; Thromboxane-A Synthase; Vasodilator Agents | 1991 |